In this section
Data is submitted annually to the NHS Newborn Blood Spot Screening Programme regarding performance of the regional newborn blood spot programme in relation to key process and clinical referral standards.
Avoidable repeat reports are produced monthly and a comprehensive performance report is produced quarterly.
Monthly avoidable repeat reports
- July 2023 (amended)
- August 2023
- September 2023
- October 2023
- November 2023
- December 2023
- January 2024
- February 2024
- March 2024
- April 2024
- May 2024
- June 2024
- July 2024
- August 2024
- September 2024
- October 2024
- November 2024
- December 2024
Quarterly reports
- Quarter 1 2022/23
- Quarter 2 2022/23
- Quarter 3 2022/23
- Quarter 4 2022/23
- Quarter 1 2023/24
- Quarter 2 2023/24
- Quarter 3 2023/24
- Quarter 4 2023/24
- Quarter 1 2024/25
- Quarter 2 2024/25
Other reports/audits
- Newborn Screening Sickle Carrier Re-Audit, June 2024
- Newborn Screening Carrier Audit, July 2022
- Audit of the linkage of antenatal and newborn screening results in the Sickle Cell and Thalassaemia Screening Programme in Greater Manchester, Lancashire and South Cumbria, May 2018
- Carriers of abnormal haemoglobins – result communication audit by Helen Jopling, November 2014
- Sickle Screening Turnaround Time Re-audit by Suzanne Armitage, May 2014
- Blood spot sample quality project by Laura Hamilton, April 2013
- Postal audit by Helen Jopling, December 2012
(Last reviewed February 2025)